Negative regulation of β-catenin/Tcf signaling by naringenin in AGS gastric cancer cell
- 1 September 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 335 (3) , 771-776
- https://doi.org/10.1016/j.bbrc.2005.07.146
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Inhibition of β-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H2O2 at physiologically relevant EGCG concentrationsBiochemical and Biophysical Research Communications, 2002
- Sophoranone, extracted from a traditional Chinese medicine Shan Dou Gen, induces apoptosis in human leukemia U937 cells via formation of reactive oxygen species and opening of mitochondrial permeability transition poresInternational Journal of Cancer, 2002
- Frequent β-catenin aberration in human hepatocellular carcinomaHepatology Research, 2001
- The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signalingOncogene, 2001
- Gastrin is a target of the β-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposisJournal of Clinical Investigation, 2000
- Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APCScience, 1997
- Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogenCancer Letters, 1997
- Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex AssemblyScience, 1996
- Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinomaHuman Molecular Genetics, 1992
- Modulating effect of plant flavonoids on the mutagenicity of N-methyl-N′ -nitro-N-nitrosoguanidineCarcinogenesis: Integrative Cancer Research, 1989